+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group



Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group



British Journal of Urology 82(5): 704-709



To study the long-term efficacy and safety of desmopressin treatment in children with primary monosymptomatic nocturnal enuresis. Children (aged 6-12 years) with nocturnal enuresis were recruited into an open multicentre trial. All children underwent an observation period of 4 weeks before starting a 6-week dose-titration period with desmopressin. If the number of wet nights decreased by more than half during medication, they began long-term treatment on 20-40 microg desmopressin. To test for cure and avoid overtreatment, the medication was interrupted for one week every third month. Of the 399 children forming the intention-to-treat cohort, 245 halved their number of wet nights and started long-term treatment. During the periods off medication, 77 children were dry and at the end of the study another 73 (still on medication) reduced the number of wet nights to < or =10% of that during the observation period. A further 51 children halved the number of wet nights compared with the observation period. No serious adverse events occurred. Long-term treatment with nasal desmopressin at a main dose of 40 microg is an effective and safe treatment for monosymptomatic nocturnal enuresis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046573769

Download citation: RISBibTeXText

PMID: 9839587


Related references

Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Swedish Enuresis Trial Group. Acta Paediatrica 88(11): 1274-1278, 1999

Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: An open multicentre study. BJU 82(5): 704-709, 1998

Efficacy of an enuresis alarm, desmopressin, and combination therapy in the treatment of saudi children with primary monosymptomatic nocturnal enuresis. Korean Journal of Urology 54(11): 783-790, 2013

Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatrica 88(11): 1274-1278, 1999

Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. Journal of Urology 184(6): 2521-2526, 2010

Role of Urodynamic Study in Nocturnal Enuresis: Urodynamic Findings and Treatment Outcome Correlation in Children with Pharmacotherapy-resistant Monosymptomatic Nocturnal Enuresis or Severe Non-monosymptomatic Nocturnal Enuresis. Lower Urinary Tract Symptoms 6(2): 88-93, 2014

Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study. Pediatric Nephrology 29(7): 1195-1200, 2015

Desmopressin in a long-term treatment of children with primary nocturnal enuresis: A symptomatic therapy?. European Journal of Pediatrics 160(3): 197-198, 2001

Long-term treatment with desmopressin in children with primary nocturnal enuresis. An international multicenter study. Casopis Lekaru Ceskych 138(14): 429-435, 1999

Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis. International Journal of Urology 24(9): 698-702, 2017

Treatment of primary monosymptomatic nocturnal enuresis with desmopressin: Predictive factors. BJU International 88(6): 572-576, 2001

Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues. Drug Safety 33(4): 261-271, 2010

Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study. International Journal of Clinical Practice 63(1): 35-45, 2009

Long-term efficacy of oral desmopressin in children with primary nocturnal enuresis. Pediatrics 100(3 PART 2): 579, 1997

Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis. European Journal of Pediatrics 172(9): 1235-1242, 2014